Table of Content

Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation Validation
2.7. Assumptions and Limitations
3.Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4.Voice of Customer
5.Global Gene Editing Technologies Market Outlook
5.1. Market Size Forecast
5.1.1. By Value
5.2. Market Share Forecast
5.2.1. By Offerings (Gene Editing Products, Gene Editing Services)
5.2.1.1. By Gene Editing Products (Kits and Enzymes, Antibodies, Libraries, Accessories)
5.2.2. By Technology (CRISPR Gene Editing Technology, Non-CRISPR Gene Editing Technology (Zinc-Finger Nucleases (ZFNs), TAL Effector Nucleases (TALENs), Meganucleases)
5.2.3. By Application (Agricultural, Biomedical (Drug Discovery, Gene Therapy, Diagnostics))
5.2.4. By End User (Academic Institutes and Research Centers, Life Sciences Companies, Contract Research Organizations (CROs)/Contract Manufacturing Organizations (CMOs))
5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
5.2.6. By Company (2023)
5.3. Market Map
5.3.1. By Offerings
5.3.2. By Technology
5.3.3. By Application
5.3.4. By End User
5.3.5. By Region
6.North America Gene Editing Technologies Market Outlook
6.1. Market Size Forecast
6.1.1. By Value
6.2. Market Share Forecast
6.2.1. By Offerings
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3.North America: Country Analysis
6.3.1.United States Gene Editing Technologies Market Outlook
6.3.1.1.Market Size Forecast
6.3.1.1.1.By Value
6.3.1.2.Market Share Forecast
6.3.1.2.1. By Offerings
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2.Canada Gene Editing Technologies Market Outlook
6.3.2.1.Market Size Forecast
6.3.2.1.1.By Value
6.3.2.2.Market Share Forecast
6.3.2.2.1. By Offerings
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3.Mexico Gene Editing Technologies Market Outlook
6.3.3.1.Market Size Forecast
6.3.3.1.1.By Value
6.3.3.2.Market Share Forecast
6.3.3.2.1. By Offerings
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7.Europe Gene Editing Technologies Market Outlook
7.1. Market Size Forecast
7.1.1. By Value
7.2. Market Share Forecast
7.2.1. By Offerings
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3.Europe: Country Analysis
7.3.1.Germany Gene Editing Technologies Market Outlook
7.3.1.1.Market Size Forecast
7.3.1.1.1.By Value
7.3.1.2.Market Share Forecast
7.3.1.2.1. By Offerings
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2.France Gene Editing Technologies Market Outlook
7.3.2.1.Market Size Forecast
7.3.2.1.1.By Value
7.3.2.2.Market Share Forecast
7.3.2.2.1. By Offerings
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3.United Kingdom Gene Editing Technologies Market Outlook
7.3.3.1.Market Size Forecast
7.3.3.1.1.By Value
7.3.3.2.Market Share Forecast
7.3.3.2.1. By Offerings
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4.Italy Gene Editing Technologies Market Outlook
7.3.4.1.Market Size Forecast
7.3.4.1.1.By Value
7.3.4.2.Market Share Forecast
7.3.4.2.1. By Offerings
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5.Spain Gene Editing Technologies Market Outlook
7.3.5.1.Market Size Forecast
7.3.5.1.1.By Value
7.3.5.2.Market Share Forecast
7.3.5.2.1. By Offerings
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8.Asia-Pacific Gene Editing Technologies Market Outlook
8.1. Market Size Forecast
8.1.1. By Value
8.2. Market Share Forecast
8.2.1. By Offerings
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3.Asia-Pacific: Country Analysis
8.3.1.China Gene Editing Technologies Market Outlook
8.3.1.1.Market Size Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share Forecast
8.3.1.2.1. By Offerings
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2.Japan Gene Editing Technologies Market Outlook
8.3.2.1.Market Size Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share Forecast
8.3.2.2.1. By Offerings
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3.India Gene Editing Technologies Market Outlook
8.3.3.1.Market Size Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share Forecast
8.3.3.2.1. By Offerings
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4.South Korea Gene Editing Technologies Market Outlook
8.3.4.1.Market Size Forecast
8.3.4.1.1.By Value
8.3.4.2.Market Share Forecast
8.3.4.2.1. By Offerings
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5.Australia Gene Editing Technologies Market Outlook
8.3.5.1.Market Size Forecast
8.3.5.1.1.By Value
8.3.5.2.Market Share Forecast
8.3.5.2.1. By Offerings
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9.South America Gene Editing Technologies Market Outlook
9.1. Market Size Forecast
9.1.1. By Value
9.2. Market Share Forecast
9.2.1. By Offerings
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3.South America: Country Analysis
9.3.1.Brazil Gene Editing Technologies Market Outlook
9.3.1.1.Market Size Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share Forecast
9.3.1.2.1. By Offerings
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2.Argentina Gene Editing Technologies Market Outlook
9.3.2.1.Market Size Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share Forecast
9.3.2.2.1. By Offerings
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3.Colombia Gene Editing Technologies Market Outlook
9.3.3.1.Market Size Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share Forecast
9.3.3.2.1. By Offerings
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10.Middle East and Africa Gene Editing Technologies Market Outlook
10.1. Market Size Forecast
10.1.1. By Value
10.2. Market Share Forecast
10.2.1. By Offerings
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3.MEA: Country Analysis
10.3.1.UAE Gene Editing Technologies Market Outlook
10.3.1.1.Market Size Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share Forecast
10.3.1.2.1. By Offerings
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2.Saudi Arabia Gene Editing Technologies Market Outlook
10.3.2.1.Market Size Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share Forecast
10.3.2.2.1. By Offerings
10.3.2.2.2. By Technology
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3.South Africa Gene Editing Technologies Market Outlook
10.3.3.1.Market Size Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share Forecast
10.3.3.2.1. By Offerings
10.3.3.2.2. By Technology
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11.Market Dynamics
11.1. Drivers
11.2. Challenges
12.Market Trends Developments
13.Competitive Landscape
13.1. Addgene Inc.
13.1.1. Business Overview
13.1.2. Product Offerings
13.1.3. Recent Developments
13.1.4. Financials (In Case of Listed Companies)
13.1.5. Key Personnel
13.2. BRAIN Biotech AG
13.3. Cellectis S.A.
13.4. Creative Biolabs, Inc.
13.5. CRISPR Therapeutics AG
13.6. DNA Script SAS
13.7. Gene Copoeia, Inc.
13.8. Merck KgaA
13.9. PerkinElmer Inc.
13.10. BioRad Laboratories Inc.
14.Strategic Recommendations
15. About Us Disclaimer